Yukihiko Kawasaki Selected Research

Yukihiko Kawasaki Research Topics

Disease

17	Proteinuria 05/2018 - 05/2005
16	Nephritis 10/2019 - 04/2003
13	IGA Glomerulonephritis (IGA Nephropathy) 06/2022 - 01/2004
13	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2018 - 12/2002
12	Infections 04/2022 - 05/2002
12	Hematuria 08/2018 - 01/2004
12	Glomerulonephritis 10/2016 - 07/2004
10	Human Influenza (Influenza) 01/2018 - 05/2002
10	Purpura 01/2013 - 08/2004
7	Hemolytic-Uremic Syndrome 01/2022 - 08/2004
7	Respiratory Syncytial Virus Infections 06/2011 - 05/2002
5	Obesity 01/2023 - 01/2014
5	Hypertension (High Blood Pressure) 01/2015 - 12/2008
5	Erythema elevatum diutinum 01/2013 - 06/2010
4	Disseminated Intravascular Coagulation 02/2023 - 10/2013
4	Body Weight (Weight, Body) 01/2023 - 03/2015
4	Inflammation (Inflammations) 06/2022 - 10/2005
4	Subacute Sclerosing Panencephalitis (SSPE) 08/2020 - 04/2013
4	Brain Diseases (Brain Disorder) 02/2013 - 05/2005
3	Renal Insufficiency (Renal Failure) 08/2023 - 03/2005
3	Neoplasms (Cancer) 01/2022 - 10/2005
3	Gastroenteritis 07/2021 - 02/2008
3	Disease Progression 12/2019 - 02/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2018 - 12/2008
3	Fever (Fevers) 05/2018 - 05/2002
3	Liver Diseases (Liver Disease) 04/2017 - 01/2014
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2016 - 03/2005
3	Hyperlipidemias (Hyperlipidemia) 01/2015 - 06/2007
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2012 - 01/2005
3	IgA Vasculitis (Purpura, Schoenlein Henoch) 04/2011 - 03/2007
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2011 - 02/2007
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 01/2022
2	Birth Weight (Birth Weights) 02/2023 - 01/2018
2	Intussusception 01/2023 - 07/2021
2	Edema (Dropsy) 04/2020 - 06/2008
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2019 - 01/2018
2	Thrombocytopenia (Thrombopenia) 12/2019 - 10/2013
2	Leukocytosis (Pleocytosis) 08/2019 - 05/2002
2	Polycythemia (Erythrocytosis) 03/2017 - 12/2014
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2016 - 06/2013
2	Tonsillitis 06/2016 - 11/2006
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 03/2016 - 08/2007
2	Sclerosis 01/2016 - 05/2009

Drug/Important Bio-Agent (IBA)

17	Immunoglobulin A (IgA)IBA 08/2023 - 01/2004
16	Proteins (Proteins, Gene)FDA Link 08/2023 - 03/2005
13	SteroidsIBA 01/2021 - 12/2002
12	Methylprednisolone FDA LinkGeneric 06/2022 - 04/2003
11	Prednisolone (Predate)FDA LinkGeneric 06/2022 - 01/2004
11	mizoribineIBA 06/2016 - 01/2004
9	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2018 - 01/2005
8	CreatinineIBA 12/2019 - 03/2005
8	CytokinesIBA 01/2018 - 05/2002
8	Antigen-Antibody Complex (Immune Complex)IBA 01/2016 - 03/2006
6	Drug CombinationsIBA 02/2018 - 10/2011
5	Interleukin-6 (Interleukin 6)IBA 11/2023 - 05/2002
5	Anti-Bacterial Agents (Antibiotics)IBA 05/2018 - 11/2003
5	InterleukinsIBA 01/2018 - 10/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015 - 05/2002
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2013 - 04/2003
4	VaccinesIBA 01/2023 - 02/2011
4	EnzymesIBA 06/2022 - 04/2004
4	Complement System Proteins (Complement)IBA 06/2022 - 12/2005
4	AntibodiesIBA 08/2020 - 09/2003
4	Antiviral Agents (Antivirals)IBA 01/2019 - 09/2009
4	Warfarin (Coumadin)FDA LinkGeneric 06/2016 - 11/2004
4	Neuraminidase (Sialidase)IBA 12/2015 - 07/2014
4	Oseltamivir (Tamiflu)FDA Link 07/2015 - 11/2003
3	Dacarbazine (DIC)FDA LinkGeneric 02/2023 - 10/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2014
3	Immunosuppressive Agents (Immunosuppressants)IBA 06/2022 - 03/2007
3	Immunoglobulin E (IgE)IBA 04/2022 - 09/2003
3	AntigensIBA 04/2022 - 04/2004
3	oxidized low density lipoproteinIBA 01/2022 - 06/2007
3	Shiga Toxin (Shigella Toxin)IBA 01/2022 - 06/2015
3	Immunoglobulin G (IgG)IBA 08/2020 - 07/2004
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2009
3	InterferonsIBA 01/2019 - 12/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 01/2012
3	Zanamivir (Relenza)FDA Link 12/2015 - 07/2014
3	ChemokinesIBA 12/2015 - 06/2006
2	Fibrinogen (Factor I)FDA Link 02/2023 - 12/2019
2	fibrin fragment D (D-dimer)IBA 02/2023 - 10/2013
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 03/2017
2	LipopolysaccharidesIBA 01/2022 - 12/2019
2	Oxygen (Dioxygen)IBA 01/2020 - 04/2004
2	C-Reactive ProteinIBA 08/2019 - 05/2002
2	Rituximab (Mabthera)FDA Link 05/2018 - 03/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2018 - 03/2012
2	peramivirIBA 01/2018 - 03/2015
2	Thymidine Monophosphate (TMP)IBA 01/2017 - 06/2016
2	DilazepIBA 06/2016 - 12/2010
2	ThrombomodulinIBA 06/2015 - 10/2013

Therapy/Procedure

38	Therapeutics 06/2022 - 04/2003
8	Tonsillectomy 06/2022 - 11/2006
5	Plasmapheresis 01/2013 - 08/2004
3	Nuclear Power Plants 09/2020 - 12/2014
3	Aftercare (After-Treatment) 12/2018 - 11/2014
2	Mechanical Ventilators (Ventilator) 04/2022 - 04/2004
2	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2016
2	Transplantation 01/2022 - 11/2021